News
CARLSBAD, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that managem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback